Print this page    •   Back to Web version of article

CRIA Update
Table of Contents, Spring 1999

About This Issue

Our Spring 1999 issue of CRIA Update focuses on reports from the Sixth Retrovirus Conference in Chicago this past February-March, one of the most important annual conferences for the presentation of research related to antiretroviral therapy. Frequent CRIA Update contributor Tim Horn heads up this issue with his look at updates in protease-sparing therapies. Carlos Arboleda and Jill Cadman weigh in with their report on the newest developments on HIV resistance tests. Dr. Shaffik Essajee, a pediatric AIDS doctor at Bellevue Hospital, reports on the latest findings around vertical transmission, and Richard Jeffreys does the same for immune-based therapies. And outgoing CRIA medical director Dr. Marshall Glesby files updates on fat redistribution and metabolic complications, and on intermittent HIV therapy.

We hope you find these updates as enlightening and hopeful as we did ... and happy spring!


CRIA co-sponsors monthly educational forums on AIDS research and treatment issues. Upcoming forums:

Wednesday, April 14
Switching Therapies: Treatment Failure and Resistance

Wednesday, May 12
Cervical and Anal Cancers

Wednesday, June 9
Drug Interactions

The forums are held at 7PM in the Cronin Auditorium, 10th Floor of St. Vincent's Hospital at 11th Street and 7th Avenue, Manhattan. Forum summaries are now available on CRIA's Website.

This article was provided by AIDS Community Research Initiative of America. It is a part of the publication CRIA Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.